MedGenome Secures Majority Stake in Green Cross Genetics Lab to Expand Diagnostics in Western India
MedGenome, a leader in genomics, has announced a majority investment in Gujarat-based pathology chain Green Cross Genetics Lab. This move strengthens its footprint in western India, merging trusted diagnostics with advanced genetic testing to enhance precision healthcare access amid rising demand for early disease detection.
Legacy Meets Cutting-Edge Genomics
Founded over three decades ago by Vinod Patel, Green Cross operates 17 laboratories and 35 collection centers across Gujarat, backed by senior pathology experts focused on precision and reliability. Its promoters will continue leading post-investment, ensuring continuity.
- Portfolio of over 800 diagnostic tests
- Team exceeding 500 professionals
- Three-decade legacy of trust in Tier 2 and Tier 3 cities
MedGenome brings South Asia’s largest CAP-accredited multiomics lab, powered by AI and machine learning for data-driven insights into complex diseases. Dr. Vedam Ramprasad, MedGenome CEO, emphasized how this aligns with affordable omics solutions, positioning Indian genomics globally.
Strategic Synergies for Broader Impact
Vinod Patel highlighted the fusion of Green Cross’s infrastructure, distribution, and clinical expertise with MedGenome’s genomics platform. This creates a comprehensive service menu, integrating actionable genetic tests into routine diagnostics.
In India’s evolving healthcare landscape, where chronic diseases like cancer and diabetes surge, such partnerships address gaps in accessible precision medicine. Genomics enables earlier interventions, reducing long-term costs and improving outcomes, especially in underserved western regions.
Implications for Precision Healthcare Nationwide
The collaboration promises scalable solutions, blending networks to deliver advanced testing. As precision diagnostics gain traction—projected to grow 15-20% annually in India—it democratizes genomics beyond metros, tackling disparities and fostering proactive health management.
By embedding AI-driven insights into widespread pathology services, MedGenome and Green Cross set a model for hybrid diagnostics, potentially influencing national health trends toward preventive, data-informed care.
